{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:18Z","timestamp":1794047478444,"version":"4.8.0"},"reference-count":49,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"11","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Hematologic cancers are among the most common cancers in adults and children. Despite significant improvements in therapies, many patients still succumb to the disease. Therefore, novel therapies are needed. The Wiskott-Aldrich syndrome protein (WASp) family regulates actin assembly in conjunction with the Arp2\/3 complex, a ubiquitous nucleation factor. WASp is expressed exclusively in hematopoietic cells and exists in two allosteric conformations: autoinhibited or activated. Here, we describe the development of EG-011, a first-in-class small molecule activator of the autoinhibited form of WASp. EG-011 possesses in vitro and in vivo antitumor activity as a single agent in lymphoma, leukemia, and multiple myeloma, including models of secondary resistance to PI3K, BTK, and proteasome inhibitors. The in vitro activity was confirmed in a lymphoma xenograft. Actin polymerization and WASp binding were demonstrated using multiple techniques. Transcriptome analysis highlighted homology with drugs inducing actin polymerization.<\/jats:p>","DOI":"10.3324\/haematol.2022.282672","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T04:20:34Z","timestamp":1718857234000},"page":"3602-3614","source":"Crossref","is-referenced-by-count":4,"title":["A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers"],"prefix":"10.3324","volume":"109","author":[{"given":"Filippo","family":"Spriano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Sgrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barnabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J.","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Guala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Carrasco","family":"Del Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan R.","family":"Tomasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tarantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Cascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetanina","family":"Golino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Riveiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bortolozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paduano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Rezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Margheriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Guarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giosu\u00e8","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk M.","family":"Verdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel I.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Stathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digvijay","family":"Gahtory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurits","family":"Van den Nieuwboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Bornhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alcaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Trapasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Cristobal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shae B.","family":"Padrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalina","family":"Pazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"68372","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49.","DOI":"10.3322\/caac.21820"},{"key":"68373","doi-asserted-by":"crossref","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017; 390(10091):298-310.","DOI":"10.1016\/S0140-6736(16)32407-2"},{"key":"68374","doi-asserted-by":"crossref","unstructured":"Younes A, Ansell S, Fowler N. The landscape of new drugs in lymphoma. Nat Rev Clin Oncol. 2017; 14(6):335-346.","DOI":"10.1038\/nrclinonc.2016.205"},{"key":"68375","doi-asserted-by":"crossref","unstructured":"Kurisu S, Takenawa T. The WASP and WAVE family proteins. Genome Biol. 2009; 10(6):226.","DOI":"10.1186\/gb-2009-10-6-226"},{"key":"68376","doi-asserted-by":"crossref","unstructured":"Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013; 1285:26-43.","DOI":"10.1111\/nyas.12049"},{"key":"68377","doi-asserted-by":"crossref","unstructured":"Keszei M, Record J, Kritikou JS. Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive. J Clin Invest. 2018; 128(9):4115-4131.","DOI":"10.1172\/JCI64772"},{"key":"68378","doi-asserted-by":"crossref","unstructured":"Westerberg LS, Meelu P, Baptista M. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes. J Exp Med. 2010; 207(6):1145-1152.","DOI":"10.1084\/jem.20091245"},{"key":"68379","doi-asserted-by":"crossref","unstructured":"Kenney D, Cairns L, Remold-O\u2019Donnell E, Peterson J, Rosen FS, Parkman R. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood. 1986; 68(6):1329-1332.","DOI":"10.1182\/blood.V68.6.1329.bloodjournal6861329"},{"key":"68380","doi-asserted-by":"crossref","unstructured":"Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM, Gout I. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr Biol. 1996; 6(8):981-988.","DOI":"10.1016\/S0960-9822(02)00642-5"},{"key":"68381","doi-asserted-by":"crossref","unstructured":"Sakuma C, Sato M, Takenouchi T, Kitani H. Specific binding of the WASP N-terminal domain to Btk is critical for TLR2 signaling in macrophages. Mol Immunol. 2015; 63(2):328-336.","DOI":"10.1016\/j.molimm.2014.08.004"},{"key":"68382","doi-asserted-by":"crossref","unstructured":"Westerberg L, Larsson M, Hardy SJ, Fernandez C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005; 105(3):1144-1152.","DOI":"10.1182\/blood-2004-03-1003"},{"key":"68383","doi-asserted-by":"crossref","unstructured":"Shimizu M, Nikolov NP, Ueno K. Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency. Clin Immunol. 2012; 142(2):160-166.","DOI":"10.1016\/j.clim.2011.10.001"},{"key":"68384","doi-asserted-by":"crossref","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994; 125(6 Pt 1):876-885.","DOI":"10.1016\/S0022-3476(05)82002-5"},{"key":"68385","doi-asserted-by":"crossref","unstructured":"Murga-Zamalloa CA, Mendoza-Reinoso V, Sahasrabuddhe AA. NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma. Oncogene. 2017; 36(15):2085-2094.","DOI":"10.1038\/onc.2016.366"},{"key":"68386","doi-asserted-by":"crossref","unstructured":"Menotti M, Ambrogio C, Cheong TC. Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma. Nat Med. 2019; 25(1):130-140.","DOI":"10.1038\/s41591-018-0262-9"},{"key":"68387","doi-asserted-by":"crossref","unstructured":"Pollitt AY, Insall RH. WASP and SCAR\/WAVE proteins: the drivers of actin assembly. J Cell Sci. 2009; 122(Pt 15):2575-2578.","DOI":"10.1242\/jcs.023879"},{"key":"68388","doi-asserted-by":"crossref","unstructured":"Luan Q, Zelter A, MacCoss MJ, Davis TN, Nolen BJ. Identification of Wiskott-Aldrich syndrome protein (WASP) binding sites on the branched actin filament nucleator Arp2\/3 complex. Proc Natl Acad Sci U S A. 2018; 115(7):E1409-E1418.","DOI":"10.1073\/pnas.1716622115"},{"key":"68389","doi-asserted-by":"crossref","unstructured":"Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 2000; 404(6774):151-158.","DOI":"10.1038\/35004513"},{"key":"68390","doi-asserted-by":"crossref","unstructured":"Higgs HN, Pollard TD. Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2\/3 complex. J Cell Biol. 2000; 150(6):1311-1320.","DOI":"10.1083\/jcb.150.6.1311"},{"key":"68391","doi-asserted-by":"crossref","unstructured":"Cory GO, Cramer R, Blanchoin L, Ridley AJ. Phosphorylation of the WASP-VCA domain increases its affinity for the Arp2\/3 complex and enhances actin polymerization by WASP. Mol Cell. 2003; 11(5):1229-1239.","DOI":"10.1016\/S1097-2765(03)00172-2"},{"key":"68392","doi-asserted-by":"crossref","unstructured":"Padrick SB, Cheng HC, Ismail AM. Hierarchical regulation of WASP\/WAVE proteins. Mol Cell. 2008; 32(3):426-438.","DOI":"10.1016\/j.molcel.2008.10.012"},{"key":"68393","doi-asserted-by":"crossref","unstructured":"Padrick SB, Rosen MK. Physical mechanisms of signal integration by WASP family proteins. Annu Rev Biochem. 2010; 79:707-735.","DOI":"10.1146\/annurev.biochem.77.060407.135452"},{"key":"68394","doi-asserted-by":"crossref","unstructured":"Peterson JR, Bickford LC, Morgan D. Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat Struct Mol Biol. 2004; 11(8):747-755.","DOI":"10.1038\/nsmb796"},{"key":"68395","doi-asserted-by":"crossref","unstructured":"Biber G, Ben-Shmuel A, Noy E. Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies. Nat Commun. 2021; 12(1):5581.","DOI":"10.1038\/s41467-021-25842-7"},{"key":"68396","doi-asserted-by":"crossref","unstructured":"Gaudio E, Tarantelli C, Spriano F. Targeting CD205 with the antibody drug conjugate MEN1309\/OBT076 is an active new therapeutic strategy in lymphoma models. Haematologica. 2020; 105(11):2584-2591.","DOI":"10.3324\/haematol.2019.227215"},{"key":"68397","doi-asserted-by":"crossref","unstructured":"Frismantas V, Dobay MP, Rinaldi A. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. Blood. 2017; 129(11):e26-e37.","DOI":"10.1182\/blood-2016-09-738070"},{"key":"68398","doi-asserted-by":"crossref","unstructured":"Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S. Bioinformatics and Computational Biology Solutions using R and Bioconductor. 2005.","DOI":"10.1007\/0-387-29362-0"},{"key":"68399","doi-asserted-by":"crossref","unstructured":"Spriano F, Chung EYL, Gaudio E. The ETS inhibitors YK-4-279 and TK-216 are novel antilymphoma agents. Clin Cancer Res. 2019; 25(16):5167-5176.","DOI":"10.1158\/1078-0432.CCR-18-2718"},{"key":"68400","doi-asserted-by":"crossref","unstructured":"Franken H, Mathieson T, Childs D. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat Protoc. 2015; 10(10):1567-1593.","DOI":"10.1038\/nprot.2015.101"},{"key":"68401","doi-asserted-by":"crossref","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG. ZINC: a free tool to discover chemistry for biology. J Chem Inf Model. 2012; 52(7):1757-1768.","DOI":"10.1021\/ci3001277"},{"key":"68402","doi-asserted-by":"crossref","unstructured":"Arribas AJ, Napoli S, Cascione L. ERBB4-mediated signaling is a mediator of resistance to PI3K and BTK inhibitors in B-cell lymphoid neoplasms. Mol Cancer Ther. 2024; 23(3):368-380.","DOI":"10.1158\/1535-7163.MCT-23-0068"},{"key":"68403","doi-asserted-by":"crossref","unstructured":"Arribas AJ, Napoli S, Gaudio E. Secretion of IL16 is associated with resistance to ibrutinib in pre-clinical models of lymphoma. Mol Cancer Ther. 2019; 18(12_Supplement):A127-A127.","DOI":"10.1158\/1535-7163.TARG-19-A127"},{"key":"68404","doi-asserted-by":"crossref","unstructured":"Arribas AJ, Napoli S, Cascione L. Resistance to PI3Kd inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6\/PDGFRA axis. Haematologica. 2022; 107(11):2685-2697.","DOI":"10.3324\/haematol.2021.279957"},{"key":"68405","doi-asserted-by":"crossref","unstructured":"Besse A, Stolze SC, Rasche L. Carfilzomib resistance due to ABCB1\/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma. Leukemia. 2018; 32(2):391-401.","DOI":"10.1038\/leu.2017.212"},{"key":"68406","doi-asserted-by":"crossref","unstructured":"Besse L, Besse A, Mendez-Lopez M. A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis. Haematologica. 2019; 104(9):e415-e419.","DOI":"10.3324\/haematol.2018.207704"},{"key":"68407","doi-asserted-by":"crossref","unstructured":"Br\u00fcnnert D, Kraus M, St\u00fchmer T. Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(6):1666-1676.","DOI":"10.1016\/j.bbadis.2019.04.003"},{"key":"68408","unstructured":"Ullman-Culler\u00e9 MH, Foltz CJ. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci. 1999; 49(3):319-323."},{"key":"68409","doi-asserted-by":"crossref","unstructured":"Musa A, Tripathi S, Dehmer M, Emmert-Streib F. L1000 viewer: a search engine and web interface for the LINCS data repository. Front Genet. 2019; 10:557.","DOI":"10.3389\/fgene.2019.00557"},{"key":"68410","doi-asserted-by":"crossref","unstructured":"Yang W, Soares J, Greninger P. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012; 41(Database issue):D955-D961.","DOI":"10.1093\/nar\/gks1111"},{"key":"68411","doi-asserted-by":"crossref","unstructured":"Munoz P, Toscano MG, Real PJ. Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors. PLoS One. 2012; 7(6):e39091.","DOI":"10.1371\/journal.pone.0039091"},{"key":"68412","doi-asserted-by":"crossref","unstructured":"Leung DW, Morgan DM, Rosen MK. Biochemical properties and inhibitors of (N-)WASP. Methods Enzymol. 2006; 406:281-296.","DOI":"10.1016\/S0076-6879(06)06021-6"},{"key":"68413","doi-asserted-by":"crossref","unstructured":"Zigmond SH. How WASP regulates actin polymerization. J Cell Biol. 2000; 150(6):F117-120.","DOI":"10.1083\/jcb.150.6.F117"},{"key":"68414","doi-asserted-by":"crossref","unstructured":"Labno CM, Lewis CM, You D. Itk functions to control actin polymerization at the immune synapse through localized activation of Cdc42 and WASP. Curr Biol. 2003; 13(18):1619-1624.","DOI":"10.1016\/j.cub.2003.08.005"},{"key":"68415","doi-asserted-by":"crossref","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010; 70(2):440-446.","DOI":"10.1158\/0008-5472.CAN-09-1947"},{"key":"68416","doi-asserted-by":"crossref","unstructured":"Meyer CT, Wooten DJ, Paudel BB. Quantifying drug combination synergy along potency and efficacy axes. Cell Syst. 2019; 8(2):97-108.","DOI":"10.1016\/j.cels.2019.01.003"},{"key":"68417","doi-asserted-by":"crossref","unstructured":"Rosenblum MD, Shivers RR. \u2018Rings\u2019 of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere. Comp Biochem Physiol C Toxicol Pharmacol. 2000; 125(1):121-131.","DOI":"10.1016\/S0742-8413(99)00101-2"},{"key":"68418","doi-asserted-by":"crossref","unstructured":"Ong MS, Deng S, Halim CE. Cytoskeletal proteins in cancer and intracellular stress: a therapeutic perspective. Cancers (Basel). 2020; 12(1):238.","DOI":"10.3390\/cancers12010238"},{"key":"68419","doi-asserted-by":"crossref","unstructured":"Malinova D, Fritzsche M, Nowosad CR. WASp-dependent actin cytoskeleton stability at the dendritic cell immunological synapse is required for extensive, functional T cell contacts. J Leukoc Biol. 2016; 99(5):699-710.","DOI":"10.1189\/jlb.2A0215-050RR"},{"key":"68420","doi-asserted-by":"crossref","unstructured":"Kritikou JS, Oliveira MM, Record J. Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells. JCI Insight. 2021; 6(6):e140273.","DOI":"10.1172\/jci.insight.140273"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282672\/77135","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282672\/77705","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11651\/77135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:45Z","timestamp":1794046005000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282672","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}